Priya Life Science is an independent news and intelligence platform covering the pharmaceutical, biotechnology, MedTech and life-science sectors, with a focus on Ireland and Europe. We exist to give professionals, jobseekers and students accurate, timely and useful information - free of charge.
Our reporting is grounded in primary sources: company announcements, regulatory filings and registers (HPRA, EMA, FDA), ClinicalTrials.gov, government and IDA Ireland publications, and on-the-record statements. Our data products - the Irish Medicines Database, Clinical Trials Tracker, Ireland Pharma Map and jobs feed - state their sources and refresh schedules on each page. Where we analyse or estimate, we say so.
We are independently owned and editorially free. Advertising and sponsorship never influence coverage; sponsored content, if published, is clearly labelled and excluded from news sections. We do not accept payment for editorial coverage.
We use AI tools to assist with drafting, data processing and research. Every published article is reviewed, verified and approved by a human editor before publication, and responsibility for accuracy rests with our editorial team.
When we get something wrong, we fix it quickly and transparently. Significant corrections are noted on the article itself with the date of amendment. To request a correction, email info@priyalifescience.com or use our contact form - we aim to respond within two business days.
Priya Life Science was founded in 2023 by Sreepriya Prasannan and is operated from Ireland. It is not owned by, or affiliated with, any pharmaceutical company, recruiter or investor group.
All content, reporting, data, and regulatory information published on Priya Life Science are provided strictly for educational, news, and professional industry intelligence purposes. Information on this website does not constitute medical, diagnostic, therapeutic, legal, or financial advice. Healthcare decisions should always be made in consultation with licensed healthcare professionals.